Audentes Therapeutics, Inc. Active Patents
2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2020-07-31: Application 16966521; Invention TRANSCRIPTION REGULATORY ELEMENTS AND USES THEREOF; Applicant Audentes Therapeutics, Inc.; Status Patented Case.
- 2018-04-13: Application 15768071; Invention NUCLEIC ACID MOLECULES CONTAINING SPACERS AND METHODS OF USE THEREOF; Applicant Audentes Therapeutics, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-07-31 | 16966521 | TRANSCRIPTION REGULATORY ELEMENTS AND USES THEREOF | Audentes Therapeutics, Inc. | Patented Case | 2025-05-13 | 12296026 | US20210162073A1 | John T. GRAY | United States | BERTOGLIO, VALARIE E |
| 2018-04-13 | 15768071 | NUCLEIC ACID MOLECULES CONTAINING SPACERS AND METHODS OF USE THEREOF | Audentes Therapeutics, Inc. | Patented Case | 2022-01-25 | 11230720 | US20180305715A1 | John T. GRAY | United States | MARVICH, MARIA |